Fortrea Holdings (FTRE) Goodwill & Intangibles (2022 - 2026)
Fortrea Holdings (FTRE) posted Goodwill & Intangibles of $1.6 billion for Q1 2026, down 1.86% on a QoQ basis from $1.6 billion in Q4 2025, and down 18.02% year-over-year from $1.9 billion in Q1 2025.
Fortrea Holdings (FTRE) Goodwill & Intangibles (2022 - 2026) Analysis & Trends
Fortrea Holdings' Goodwill & Intangibles history runs 5 years deep, the most recent figure standing at $1.6 billion for Q1 2026.
- Quarterly Goodwill & Intangibles fell 18.02% year-over-year to $1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (down 18.02% YoY) and the FY2025 annual result came in at $1.6 billion, down 33.14% from the prior year.
- Goodwill & Intangibles was $1.6 billion for Q1 2026 at Fortrea Holdings, down from $1.6 billion in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $2.8 billion in Q3 2023 and bottomed at $1.6 billion in Q1 2026.
- A 5-year average of $2.1 billion and a median of $2.2 billion in 2022 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles jumped 42.91% — and 2025, when it slumped 35.18%.
- Fortrea Holdings' Goodwill & Intangibles stood at $2.5 billion in 2022, then dropped by 2.5% to $2.5 billion in 2023, then slipped by 4.11% to $2.4 billion in 2024, then plunged by 33.14% to $1.6 billion in 2025, then fell by 1.86% to $1.6 billion in 2026.
- Business Quant data shows FTRE's Goodwill & Intangibles at $1.6 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Bn |
| Dec 31, 2025 | 1.58 Bn |
| Sep 30, 2025 | 1.59 Bn |
| Jun 30, 2025 | 1.62 Bn |
| Mar 31, 2025 | 1.89 Bn |
| Dec 31, 2024 | 2.37 Bn |
| Sep 30, 2024 | 2.46 Bn |
| Jun 30, 2024 | 2.42 Bn |
| Mar 31, 2024 | 2.44 Bn |
| Dec 31, 2023 | 2.47 Bn |
| Sep 30, 2023 | 2.77 Bn |
| Jun 30, 2023 | 2.54 Bn |
| Mar 31, 2023 | 1.72 Bn |
| Dec 31, 2022 | 2.53 Bn |
| Sep 30, 2022 | 1.94 Bn |
| Jun 30, 2022 | 2.00 Bn |